We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Nabors Industries
NBR
$1.21B
| $2.48M | ﹤0.01% |
25,728
-667
| -3% | -$58K |
|
1777
Ironwood Pharmaceuticals
IRWD
$714M
| $2.48M | ﹤0.01% |
189,862
+6,173
| +3% | +$79.8K |
|
1778
Photronics
PLAB
$1.93B
| $2.48M | ﹤0.01% |
181,732
-27,430
| -13% | -$372K |
|
1779
Shoals Technologies Group
SHLS
$1.5B
| $2.48M | ﹤0.01% |
88,856
+3,416
| +4% | +$106K |
|
|
ONEM
1780
DELISTED
1Life Healthcare
ONEM
| $2.47M | ﹤0.01% |
122,041
+4,903
| +4% | +$126K |
|
1781
Agilysys
AGYS
$3.06B
| $2.47M | ﹤0.01% |
47,102
-8,891
| -16% | -$486K |
|
|
NSTG
1782
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.46M | ﹤0.01% |
51,322
+1,816
| +4% | +$104K |
|
1783
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $2.46M | ﹤0.01% |
69,363
+1,710
| +3% | +$57.6K |
|
1784
BJ's Restaurants
BJRI
$1.48B
| $2.46M | ﹤0.01% |
58,966
-8,213
| -12% | -$345K |
|
|
GES
1785
DELISTED
Guess Inc
GES
| $2.46M | ﹤0.01% |
117,171
-13,793
| -11% | -$315K |
|
1786
BGC Group
BGC
$4.89B
| $2.46M | ﹤0.01% |
472,289
+8,332
| +2% | +$44.2K |
|
|
CNR
1787
Core Natural Resources Inc
CNR
$4.45B
| $2.45M | ﹤0.01% |
94,172
-10,222
| -10% | -$225K |
|
1788
John B. Sanfilippo & Son
JBSS
$972M
| $2.45M | ﹤0.01% |
29,935
-2,849
| -9% | -$247K |
|
1789
Cushman & Wakefield Ltd
CWK
$3.25B
| $2.44M | ﹤0.01% |
131,005
+15,538
| +13% | +$279K |
|
|
AHRT
1790
AH Realty Trust
AHRT
$517M
| $2.44M | ﹤0.01% |
182,203
-20,796
| -10% | -$275K |
|
|
ARR
1791
Armour Residential REIT
ARR
$2.36B
| $2.44M | ﹤0.01% |
45,174
-697
| -2% | -$37.6K |
|
1792
Health Catalyst
HCAT
$128M
| $2.44M | ﹤0.01% |
48,686
+5,070
| +12% | +$277K |
|
1793
Revolve Group
RVLV
$1.73B
| $2.43M | ﹤0.01% |
39,334
+2,520
| +7% | +$164K |
|
1794
Newmark Group
NMRK
$2.63B
| $2.42M | ﹤0.01% |
169,372
+6,236
| +4% | +$80.4K |
|
|
CMRC
1795
Commerce.com Inc Series 1
CMRC
$184M
| $2.41M | ﹤0.01% |
47,663
+3,563
| +8% | +$217K |
|
1796
Zumiez
ZUMZ
$339M
| $2.41M | ﹤0.01% |
60,626
-6,631
| -10% | -$283K |
|
|
NKLA
1797
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.4M | ﹤0.01% |
7,500
+720
| +11% | +$252K |
|
|
NP
1798
DELISTED
Neenah, Inc. Common Stock
NP
| $2.4M | ﹤0.01% |
51,462
-6,301
| -11% | -$307K |
|
|
VIVO
1799
DELISTED
Meridian Bioscience Inc
VIVO
| $2.4M | ﹤0.01% |
124,612
-15,700
| -11% | -$313K |
|
|
SC
1800
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.39M | ﹤0.01% |
57,404
-4,705
| -8% | -$194K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.